Your browser doesn't support javascript.
Trust in government, intention to vaccinate and COVID-19 vaccine hesitancy: A comparative survey of five large cities in the United States, United Kingdom, and Australia.
Trent, Mallory; Seale, Holly; Chughtai, Abrar Ahmad; Salmon, Daniel; MacIntyre, C Raina.
  • Trent M; Biosecurity Research Program, The Kirby Institute, University of New South Wales, Sydney, Australia. Electronic address: mjtrent@protonmail.com.
  • Seale H; School of Population Health, University of New South Wales, Sydney, Australia. Electronic address: h.seale@unsw.edu.au.
  • Chughtai AA; School of Population Health, University of New South Wales, Sydney, Australia. Electronic address: abrar.chughtai@protonmail.com.
  • Salmon D; Institute for Vaccine Safety, Departments of International Health and Health, Behavior and Society, Bloomberg School of Public Health, Johns Hopkins University, Baltimore, MD, United States.
  • MacIntyre CR; Biosecurity Research Program, The Kirby Institute, University of New South Wales, Sydney, Australia. Electronic address: rainam@protonmail.com.
Vaccine ; 40(17): 2498-2505, 2022 04 14.
Article in English | MEDLINE | ID: covidwho-1683644
ABSTRACT

BACKGROUND:

There is widespread hesitancy towards COVID-19 vaccines in the United States, United Kingdom, and Australia.

OBJECTIVE:

To identify predictors of willingness to vaccinate against COVID-19 in five cities with varying COVID-19 incidence in the US, UK, and Australia.

DESIGN:

Online, cross-sectional survey of adults from Dynata's research panel in July-September 2020. PARTICIPANTS,

SETTING:

Adults aged 18 and over in Sydney, Melbourne, London, New York City, or Phoenix. MAIN OUTCOMES AND

MEASURES:

Willingness to receive a COVID-19 vaccine; reason for vaccine intention. STATISTICAL

METHODS:

To identify predictors of intention to receive a COVID-19 vaccine, we used Poisson regression with robust error estimation to produce prevalence ratios.

RESULTS:

The proportion willing to receive a COVID-19 vaccine was 70% in London, 71% NYC, 72% in Sydney, 76% in Phoenix, and 78% in Melbourne. Age was the only sociodemographic characteristic that predicted willingness to receive a COVID-19 vaccine in all five cities. In Sydney and Melbourne, participants with high confidence in their current government had greater willingness to receive the vaccine (PR = 1.24; 95% CI = 1.07-1.44 and PR = 1.38; 95% CI = 1.74-1.62), while participants with high confidence in their current government in NYC and Phoenix were less likely to be willing to receive the vaccine (PR = 0.78; 95% CI = 0.72-0.85 and PR = 0.85; 95% CI = 0.76-0.96).

LIMITATIONS:

Consumer panels can be subject to bias and may not be representative of the general population.

CONCLUSIONS:

Success for COVID-19 vaccination programs requires high levels of vaccine acceptance. Our data suggests more than 25% of adults may not be willing to receive a COVID-19 vaccine, but many of them were not explicitly anti-vaccination and thus may become more willing to vaccinate over time. Among the three countries surveyed, there appears to be cultural differences, political influences, and differing experiences with COVID-19 that may affect willingness to receive a COVID-19 vaccine.
Subject(s)
Keywords

Full text: Available Collection: International databases Database: MEDLINE Main subject: Vaccines / COVID-19 Type of study: Observational study / Prognostic study / Qualitative research / Randomized controlled trials Topics: Vaccines Limits: Adolescent / Adult / Humans Country/Region as subject: North America / Europa / Oceania Language: English Journal: Vaccine Year: 2022 Document Type: Article

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: Vaccines / COVID-19 Type of study: Observational study / Prognostic study / Qualitative research / Randomized controlled trials Topics: Vaccines Limits: Adolescent / Adult / Humans Country/Region as subject: North America / Europa / Oceania Language: English Journal: Vaccine Year: 2022 Document Type: Article